Italy · Delayed Price · Currency is EUR Banca Mediolanum Statistics
Total Valuation
BIT:BMED has a market cap or net worth of EUR 17.71 billion.
| Market Cap | 17.71B |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Thursday, July 30, 2026.
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | Apr 20, 2026 |
Share Statistics
BIT:BMED has 740.86 million shares outstanding. The number of shares has decreased by -0.27% in one year.
| Current Share Class | 740.86M |
| Shares Outstanding | 740.86M |
| Shares Change (YoY) | -0.27% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 10.81% |
| Float | 519.09M |
Valuation Ratios
The trailing PE ratio is 13.52 and the forward PE ratio is 15.31. BIT:BMED's PEG ratio is 119.36.
| PE Ratio | 13.52 |
| Forward PE | 15.31 |
| PS Ratio | 6.92 |
| PB Ratio | 3.87 |
| P/TBV Ratio | 4.06 |
| P/FCF Ratio | 24.48 |
| P/OCF Ratio | 24.26 |
| PEG Ratio | 119.36 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 7.11 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 30.06%.
| Return on Equity (ROE) | 30.06% |
| Return on Assets (ROA) | 1.42% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.49% |
| Revenue Per Employee | 614,602 |
| Profits Per Employee | 315,925 |
| Employee Count | 4,166 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BIT:BMED has paid 240.58 million in taxes.
| Income Tax | 240.58M |
| Effective Tax Rate | 15.45% |
Stock Price Statistics
The stock price has increased by +37.36% in the last 52 weeks. The beta is 0.75, so BIT:BMED's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | +37.36% |
| 50-Day Moving Average | 22.82 |
| 200-Day Moving Average | 19.73 |
| Relative Strength Index (RSI) | 59.45 |
| Average Volume (20 Days) | 719,866 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BIT:BMED had revenue of EUR 2.56 billion and earned 1.32 billion in profits. Earnings per share was 1.77.
| Revenue | 2.56B |
| Gross Profit | 2.55B |
| Operating Income | 1.60B |
| Pretax Income | 1.56B |
| Net Income | 1.32B |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | 1.77 |
Balance Sheet
The company has 53.92 billion in cash and 5.14 billion in debt, with a net cash position of 48.78 billion or 65.84 per share.
| Cash & Cash Equivalents | 53.92B |
| Total Debt | 5.14B |
| Net Cash | 48.78B |
| Net Cash Per Share | 65.84 |
| Equity (Book Value) | 4.58B |
| Book Value Per Share | 6.18 |
| Working Capital | -5.72B |
Cash Flow
In the last 12 months, operating cash flow was 729.95 million and capital expenditures -6.76 million, giving a free cash flow of 723.19 million.
| Operating Cash Flow | 729.95M |
| Capital Expenditures | -6.76M |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | 723.19M |
| FCF Per Share | 0.98 |
Margins
| Gross Margin | n/a |
| Operating Margin | 62.45% |
| Pretax Margin | 60.80% |
| Profit Margin | 51.40% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 28.24% |
Dividends & Yields
This stock pays an annual dividend of 1.30, which amounts to a dividend yield of 5.41%.
| Dividend Per Share | 1.30 |
| Dividend Yield | 5.41% |
| Dividend Growth (YoY) | 25.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 70.55% |
| Buyback Yield | 0.27% |
| Shareholder Yield | 5.68% |
| Earnings Yield | 7.43% |
| FCF Yield | 4.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BIT:BMED is 25.12, which is 5.11% higher than the current price. The consensus rating is "Buy".
| Price Target | 25.12 |
| Price Target Difference | 5.11% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | -8.80% |
| EPS Growth Forecast (3Y) | 1.75% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |